Trust Point Inc’s Pfizer PFE Stock Holding History

Trust Point Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Buy	67,683 +35,006	+107%	+$916K	0.14%	89
2026 Q1	$918K	Buy	32,677 +265	+0.8%	+$7.05K	0.08%	133
2025 Q4	$807K	Buy	32,412 +1,174	+4%	+$29.6K	0.06%	149
2025 Q3	$796K	Sell	31,238 -754	-2%	-$18.6K	0.06%	149
2025 Q2	$775K	Buy	31,992 +7,116	+29%	+$166K	0.07%	129
2025 Q1	$630K	Sell	24,876 -6,934	-22%	-$181K	0.06%	180
2024 Q4	$844K	Sell	31,810 -371	-1%	-$10.1K	0.06%	188
2024 Q3	$931K	Sell	32,181 -2,419	-7%	-$70.6K	0.07%	179
2024 Q2	$968K	Sell	34,600 -170	-0.5%	-$4.68K	0.08%	158
2024 Q1	$965K	Sell	34,770 -16,982	-33%	-$471K	0.08%	168
2023 Q4	$1.49M	Buy	+51,752	New	+$1.56M	0.12%	90

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Trust Point Inc's PFE Position: Q2 2026 in Review

Trust Point Inc increased its Pfizer (PFE) stake by 107% in Q2 2026, buying an estimated $916K and bringing the position to 67,683 shares worth $1.63M. The position accounts for 0.14% of the portfolio, ranked #89.

Trust Point Inc first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Trust Point Inc held 67,683 shares of Pfizer worth $1.63M as of Q2 2026.
Trust Point Inc bought 35,006 Pfizer shares in Q2 2026, an estimated $916K.
Pfizer made up 0.14% of Trust Point Inc's portfolio in Q2 2026, its #89 holding.
Trust Point Inc first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.